2 10 48 https://ciencia.lugoneseditorial.com.ar/files/original/9148013957dedd564efe2fbf679dca19.pdf 4bdc966b5180353582173cadbebe4e35 https://ciencia.lugoneseditorial.com.ar/files/original/1cc551cb13603064254de45eb350a86a.pdf 4bdc966b5180353582173cadbebe4e35 Hyperlink A link, or reference, to another resource on the Internet. URL https://lugoneseditorial.com.ar/destacada/linfoma-cutaneo-t-diagnostico/ Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Cutaneous T lymphoma, a true diagnostic challenge Description An account of the resource Cutaneous T lymphoma is a pathology that is still incurable, but compatible with long survival, in part thanks to the therapeutic arsenal currently available. The value of joint work between the hematologist and the dermatologist for adequate patient follow-up is also highlighted. Creator An entity primarily responsible for making the resource María Fernanda Cristoforetti Publisher An entity responsible for making the resource available Editorial Lugones Date A point or period of time associated with an event in the lifecycle of the resource 08/04/2024 Contributor An entity responsible for making contributions to the resource Takeda Cutaneous T lymphoma Dermatology Diagnosis Hematology Multi-disciplinary Pathological anatomy Systemic therapies Takeda Hyperlink A link, or reference, to another resource on the Internet. URL <a href="https://lugoneseditorial.com.ar/destacada/rol-vacunas-diabetes/">https://lugoneseditorial.com.ar/destacada/rol-vacunas-diabetes/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource El rol de las vacunas en la diabetes. Entrevista con el Dr. Amadeo Esposto Description An account of the resource Para las personas con diabetes, las vacunas son herramientas preventivas de gran valor ante las infecciones. La importancia de difundir el valor de la inmunización. Entrevista con el Dr. Amadeo Esposto (M.N. 13891), Médico Infectólogo, especialista jerarquizado en Medicina Interna, exjefe del Servicio de Infectología, Hospital General San Martín de La Plata. Creator An entity primarily responsible for making the resource Lic. María Fernanda Cristoforetti, Editora de Lugones Editorial Source A related resource from which the described resource is derived https://lugoneseditorial.com.ar/destacada/rol-vacunas-diabetes/ Publisher An entity responsible for making the resource available Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 27/04/2024 Contributor An entity responsible for making contributions to the resource Pfizer Amadeo Esposto Antigripal Antineumocócica Calendario de vacunación COVID-19 Dengue Diabetes Hepatitis B Herpes Zóster Inmunización Vacunas VSR Hyperlink A link, or reference, to another resource on the Internet. URL <a href="https://lugoneseditorial.com.ar/destacada/rol-vacunas-diabetes/">https://lugoneseditorial.com.ar/destacada/rol-vacunas-diabetes/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource The role of vaccines in diabetes. Interview with Dr. Amadeo Esposto Description An account of the resource For people with diabetes, vaccines are highly valuable preventive tools against infections. The importance of spreading the value of immunization. Interview with Dr. Amadeo Esposto (M.N. 13891), Infectious Diseases Doctor, senior specialist in Internal Medicine, former head of the Infectious Diseases Service, San Martín de La Plata General Hospital. Creator An entity primarily responsible for making the resource Lic. María Fernanda Cristoforetti, Editor of Lugones Editorial Source A related resource from which the described resource is derived https://lugoneseditorial.com.ar/destacada/rol-vacunas-diabetes/ Publisher An entity responsible for making the resource available Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 27/04/2024 Contributor An entity responsible for making contributions to the resource Pfizer Amadeo Esposto Anti-flu Anti-pneumococcal COVID-19 Dengue Diabetes Hepatitis B Herpes Zóster Immunization RSV Vaccination schedule Vaccines https://ciencia.lugoneseditorial.com.ar/files/original/37a93cbc15677d162bc3db847bc82f81.pdf 5e9f126e925d57252fa6089324399bad Hyperlink A link, or reference, to another resource on the Internet. URL <a href="https://lugoneseditorial.com.ar/novedades/dermatologia/hidroxiapatita-de-calcio-surcos-nasolabiales/">https://lugoneseditorial.com.ar/novedades/dermatologia/hidroxiapatita-de-calcio-surcos-nasolabiales/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Hidroxiapatita de calcio en surcos nasolabiales Description An account of the resource Evaluación de la seguridad y eficacia de la hidroxiapatita de calcio en el tratamiento de surcos nasolabiales. Creator An entity primarily responsible for making the resource Editora: María Fernanda Cristoforetti Source A related resource from which the described resource is derived I. Vera-Ramírez V, Morales-Sánchez MA, Santa-Cruz FJ, Medina-Bojórquez A. Escalas clínicas para evaluar el envejecimiento cutáneo: una revisión de la literatura. Rev Centro Dermatol Pascua 2021;2:68-75. doi: 10.35366/101176. II. Li K, Meng F, Li YR, Tian Y, Chen H, Jia Q, Cai H, Jiang HB. Application of nonsurgical modalities in improving facial aging. Int J Dent 2022 Feb 24;2022:8332631. doi: 10.1155/2022/8332631. III. Ogden S, Griffiths TW. A review of minimally invasive cosmetic procedures. Br J Dermatol 2008;159:1036-1050. doi: 10.1111/j.1365-2133.2008 .08845.x. IV. Sánchez-Carpintero I, Candelas D, Ruiz-Rodríguez R. Dermal fillers: types, indications, and complications. Actas Dermosifilogr 2010;101(5):381-393. doi: 10.1016/j. ad.2010.01.004 V. Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J 2010 Mar;30(2):235-8. doi: 10.1177/1090820X10366549. Ferreira Pacheco de Oliveira CS, da Silva Almeida TJ, de Oliveira-Martins L, Torelli Marques Sorpreso LA, Silveira Finck N. Hidroxiapatita de cálcio: uma revisão quanto àeficacia, segurança e imaginologia quando usado como preenchedor e como bioestimulador. Research Society and Development 2021;9(14):1-12. doi: 10.33448/ rsd-v10i14.21689. VII. Kadouch J. (2017). Calcium hydroxylapatite. A review on safety and complications. J Cosmet Dermatol 2017;16(2):152-161. doi: 10.1111/jocd.12326. VIII. Berlin A, Cohen JL, Goldberg DJ. Calcium hydroxylapatite for facial rejuvenation. Semin Cutan Med Surg. 2006 Sep;25(3):132-7. doi: 10.1016/j.sder.2006.06.005. IX. Tzikas TL. Evaluation of the Radiance FN soft tissue filler for facial soft tissue augmentation. Arch Facial Plast Surg 2004 Jul-Aug;6(4):234-9. doi: 10.1001/archfaci.6.4.234. X. Moher D, Liberati A, Tetzlaff J, Altman DG; PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009;6(7):e1000097. doi: 10.1371/journal.pmed.1000097. XI. Narins RS, Beer K. Liquid injectable silicone: a review of its history, immunology, technical considerations, complications, and potential. Plast Reconstr Surg 2006;118(3 Suppl):77S-84S. doi: 10.1097/01. prs.0000234919.25096.67. XII. Ahn MS. Calcium hydroxylapatite: Radiesse. Facial Plast Surg Clin North Am 2007 Feb;15(1):85-90. doi: 10.1016/j. fsc.2006.11.003. Publisher An entity responsible for making the resource available Lic. María Fernanda Cristoforetti, Editora de Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 08/07/2024 Rights Information about rights held in and over the resource Lugones Editorial Format The file format, physical medium, or dimensions of the resource Sitio web Language A language of the resource Español duración eficacia hidroxiapatita de calcio rellenos dérmicos seguridad surcos nasolabiales https://ciencia.lugoneseditorial.com.ar/files/original/fae7fc727b7cec893cd1a699fd08f204.pdf 5e9f126e925d57252fa6089324399bad Hyperlink A link, or reference, to another resource on the Internet. Local URL The URL of the local directory containing all assets of the website <a href="https://lugoneseditorial.com.ar/novedades/dermatologia/hidroxiapatita-de-calcio-surcos-nasolabiales/">https://lugoneseditorial.com.ar/novedades/dermatologia/hidroxiapatita-de-calcio-surcos-nasolabiales/</a> URL <a href="https://lugoneseditorial.com.ar/novedades/dermatologia/hidroxiapatita-de-calcio-surcos-nasolabiales/">https://lugoneseditorial.com.ar/novedades/dermatologia/hidroxiapatita-de-calcio-surcos-nasolabiales/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Calcium hydroxyapatite in nasolabial folds Description An account of the resource Evaluation of the safety and efficacy of calcium hydroxyapatite in the treatment of nasolabial folds. Creator An entity primarily responsible for making the resource Editor: María Fernanda Cristoforetti Source A related resource from which the described resource is derived I. Vera-Ramírez V, Morales-Sánchez MA, Santa-Cruz FJ, Medina-Bojórquez A. Escalas clínicas para evaluar el envejecimiento cutáneo: una revisión de la literatura. Rev Centro Dermatol Pascua 2021;2:68-75. doi: 10.35366/101176. II. Li K, Meng F, Li YR, Tian Y, Chen H, Jia Q, Cai H, Jiang HB. Application of nonsurgical modalities in improving facial aging. Int J Dent 2022 Feb 24;2022:8332631. doi: 10.1155/2022/8332631. III. Ogden S, Griffiths TW. A review of minimally invasive cosmetic procedures. Br J Dermatol 2008;159:1036-1050. doi: 10.1111/j.1365-2133.2008 .08845.x. IV. Sánchez-Carpintero I, Candelas D, Ruiz-Rodríguez R. Dermal fillers: types, indications, and complications. Actas Dermosifilogr 2010;101(5):381-393. doi: 10.1016/j.ad.2010.01.004 V. Bass LS, Smith S, Busso M, McClaren M. Calcium hydroxylapatite (Radiesse) for treatment of nasolabial folds: long-term safety and efficacy results. Aesthet Surg J 2010 Mar;30(2):235-8. doi: 10.1177/1090820X10366549. Publisher An entity responsible for making the resource available Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 08/07/2024 Format The file format, physical medium, or dimensions of the resource Website Language A language of the resource Español calcium hydroxyapatite dermal fillers duration efficacy nasolabial folds safety Hyperlink A link, or reference, to another resource on the Internet. URL <a href="https://lugoneseditorial.com.ar/novedades/dermatologia/desbridamiento-enzimatico/">https://lugoneseditorial.com.ar/novedades/dermatologia/desbridamiento-enzimatico/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Desbridamiento enzimático de heridas Description An account of the resource El desbridamiento enzimático consiste en la eliminación progresiva del tejido desnaturalizado o necrótico de las heridas llevado a cabo por enzimas de aplicación tópica. Creator An entity primarily responsible for making the resource Entrevista con el Dr. Santiago L. Laborde (M. N. 86.746), Médico especialista en Cirugía Plástica y Reconstructiva, Hospital Nacional de Pediatría J. P. Garrahan y Hospital de Quemados (CABA). Lic. María Fernanda Cristoforetti, Editora de Lugones Editorial Publisher An entity responsible for making the resource available Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 23 .07.24 Contributor An entity responsible for making contributions to the resource Abbott Language A language of the resource Español Abbott Desbridamiento enzimático Desbridamiento mecánico Desbridamiento quirúrgico Enzima colagenasa Santiago Laborde Tejido desnaturalizado Tejido desvitalizado Tejido necrótico Hyperlink A link, or reference, to another resource on the Internet. URL <a href="https://lugoneseditorial.com.ar/novedades/dermatologia/desbridamiento-enzimatico/">https://lugoneseditorial.com.ar/novedades/dermatologia/desbridamiento-enzimatico/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Enzymatic wound debridement Description An account of the resource Enzymatic debridement consists of the progressive elimination of denatured or necrotic tissue from wounds carried out by topically applied enzymes. Creator An entity primarily responsible for making the resource Interview with Dr. Santiago L. Laborde (M. N. 86,746), Specialist in Plastic and Reconstructive Surgery, J. P. Garrahan National Pediatric Hospital and Quemados Hospital (CABA). Lic. María Fernanda Cristoforetti, Editor of Lugones Editorial Publisher An entity responsible for making the resource available Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 23.07.24 Contributor An entity responsible for making contributions to the resource Abbott Abbott collagenase enzyme Denatured tissue Devitalized tissue Enzymatic debridement mechanical debridement Necrotic tissue Santiago Laborde Surgical debridement Website A resource comprising of a web page or web pages and all related assets ( such as images, sound and video files, etc. ). Local URL The URL of the local directory containing all assets of the website <a href="https://lugoneseditorial.com.ar/novedades/diabetes/diabetes-congreso-ada-2024/" target="_blank" rel="noreferrer noopener">https://lugoneseditorial.com.ar/novedades/diabetes/diabetes-congreso-ada-2024/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource La detección y prevención de la diabetes, su diagnóstico y tratamiento, sus complicaciones y comorbilidades asociadas, y el rol de la inteligencia artificial fueron algunos de los temas del Congreso ADA 2024. Entrevista con el Dr. León Litwak, Médico especialista en Endocrinología, Hospital Italiano de Buenos Aires Description An account of the resource Del 21 al 24 de junio de 2024 se celebraron las 84º Sesiones Científicas de la American Diabetes Association (Congreso ADA 2024), en Orlando (Florida), donde se presentaron múltiples novedades referidas a la detección precoz y la prevención, particularmente de la diabetes tipo 1 (DT1), el diagnóstico y tratamiento de las diferentes áreas relacionadas con la DM y la obesidad, las complicaciones y comorbilidades asociadas a la DM y la incorporación gradual de la inteligencia artificial en el campo de la diabetología. Creator An entity primarily responsible for making the resource Cristoforetti, María Fernanda Publisher An entity responsible for making the resource available Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 02.08.24 Contributor An entity responsible for making contributions to the resource Litwak, León American Diabetes Association Language A language of the resource Esp complicaciones Congreso ADA 2024León Litwak Diabetes Inteligencia artificial y comorbilidades asociadas Website A resource comprising of a web page or web pages and all related assets ( such as images, sound and video files, etc. ). Local URL The URL of the local directory containing all assets of the website <a href="https://lugoneseditorial.com.ar/novedades/dermatologia/tratamiento-pie-diabetico/">https://lugoneseditorial.com.ar/novedades/dermatologia/tratamiento-pie-diabetico/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Abordaje y tratamiento del pie diabético Description An account of the resource El abordaje del pie diabético implica un proceso multidisciplinario y para su tratamiento la enzima proteolítica colagenasa demostró ser una aliada invaluable para la cicatrización de heridas, con excelente tolerancia. Creator An entity primarily responsible for making the resource Lic. María Fernanda Cristoforetti, Editora de Lugones Editorial Source A related resource from which the described resource is derived 1. International Diabetes Federation. IDF Diabetes Atlas, 10th ed. https://diabetesatlas.org/atlas/tenth-edition/ 2. Instituto Nacional de Estadística y Censos (INDEC). Cuarta Encuesta Nacional de Factores de Riesgo. Resultados definitivos. 1a ed. Ciudad Autónoma de Buenos Aires. 3. Zhang Y, Lazzarini PA, McPhail SM, vanNetten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care 2020;43(5):964974. doi:10.2337/dc19-1614. 4. Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin North Am 2013;97:775-790 (2013). doi: 10.1016/j.mcna.2013.03.007. 5. Armstrong DG, Boulton AJM, BusSA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376(24):2367-2375. doi:10.1056/NEJMra1615439. 6. Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med 2018;35(1):78-88. doi:10.1111/dme.13537. 7. Carro GV, Saurral R, Sagüez FS, Witman EL, Carrió M, Duturo CF, Dicatarina-Losada, MV, Braver JD, Illuminati G, Torres JC, David RA, Maldonado N. (2023). Estudio de diabetes mellitus y pie diabético en la internación: datos de Argentina. Rev Soc Arg Diab 2019;53(1):3-15. doi: 10.47196/diab.v53i1.136. 8. Senneville É, Albalawi Z, van Asten SA, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes: IWGDF/IDSA 2023. Diabetes Metab Rews Rev 2024;40(3):e3687. doi: 10.1002/dmrr.3687. 9. Ministerio de Salud de la Nación Argentina. Pautas para la prevención y el abordaje del pie diabético. Disponible en: https://bancos.salud.gob.ar/recurso/pautas-para-la-prevencion-y-el-abordaje-del-pie-diabetico. 10. IWGDF 2023 update. Guidelines on the classification of foot ulcers in people with diabetes. Disponible en: IWGDF Classification Guideline 2023 https://iwgdfguidelines.org/wp-content/uploads/2023/07/IWGDF-2023-03-Classification-Guideline.pdf 11. Carro GV, Saurral R, Carlucci E, Gette F, Llanos MLÁ, Amato PS. A comparison between diabetic foot classifications WIfI, Saint Elian, and Texas. Description of wounds and clinical outcomes. Int J Low Extrem Wounds 2022 Jun;21(2):120-130. doi: 10.1177/1534734620930171. 12. Carro GV, Saurral RN, Issa CM, Witman EL, Carrió M. Validación de clasificaciones de pie diabético en Argentina. Rev Soc Arg Diab 2023;57(2):84-94. doi: 10.47196/diab.v57i2.625. 13. Lazzarini PA, Pacella RE, Armstrong DG, van Netten JJ. Diabetes-related lower-extremity complications are a leading cause of the global burden of disability. Diabet Med 2018 May 23. doi: 10.1111/dme.13680. 14. Vainieri E, Ahluwalia R, Slim H, Vas PRJ. Outcomes after emergency admission with a diabetic foot attack indicate a high rate of healing and limb salvage but increased mortality: 18-month follow-up study. Exp Clin Endocrinol Diabetes 2022 Mar;130(3):165-171. doi: 10.1055/a-1322-4811. 15. Atkin L, Bućko Z, Conde-Montero E. Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care 2019 Mar 1;23(Sup3a):S1-S50. doi: 10.12968/jowc.2019.28.Sup3a.S1. 16. Lantis-li JCL, Gordon I. Clostridial collagenase for the management of diabetic foot ulcers. Results of four randomized controlled trials. Wounds 2017;29(10):297-305. doi: 10.25270/wnds/2017.10.297305. 17. De Decker I, De Graeve L, Hoeksema H, Monstrey S, Verbelen J, De Coninck P, Vanlerberghe E, Claes KEY. Enzymatic debridement: past, present, and future. Acta Chir Belg 2022 Aug;122(4):279-295. doi: 10.1080/00015458.2022.2068746. 18. Chen L, Sun S, Gao Y, Ran X. Global mortality of diabetic foot ulcer. A systematic review and meta-analysis of observational studies. Diabetes Obes Metab 2023;25(1):36-45. doi: 10.1111/dom.14840. Publisher An entity responsible for making the resource available Lic. María Fernanda Cristoforetti, Editora de Lugones Editorial Date A point or period of time associated with an event in the lifecycle of the resource 05/11/2024 Contributor An entity responsible for making contributions to the resource Abbott Laboratories Language A language of the resource Español Abbott Abordaje Diabetes Enzima proteolítica colagenasa Mabel Carrió pie diabético Tratamiento Úlcera pie diabético Hyperlink A link, or reference, to another resource on the Internet. URL <a href="https://lugoneseditorial.com.ar/novedades/dermatologia/tratamiento-pie-diabetico/">https://lugoneseditorial.com.ar/novedades/dermatologia/tratamiento-pie-diabetico/</a> Dublin Core The Dublin Core metadata element set is common to all Omeka records, including items, files, and collections. For more information see, http://dublincore.org/documents/dces/. Title A name given to the resource Approach and treatment of diabetic foot Subject The topic of the resource The approach to diabetic foot involves a multidisciplinary process and for its treatment the proteolytic enzyme collagenase proved to be an invaluable ally for wound healing, with excellent tolerance. Description An account of the resource Interview with Dr. Mabel Carrió (M.N. 68739), Diabetologist, Director of the Dr. Alberto Maggio Municipal Diabetes Center and the Malvinas Argentinas Diabetic Foot Day Hospital, Director of the Diabetic Foot Diploma, Universidad Nacional del Nordeste (UNNE) Creator An entity primarily responsible for making the resource Mabel Carrió Source A related resource from which the described resource is derived 1. International Diabetes Federation. IDF Diabetes Atlas, 10th ed. https://diabetesatlas.org/atlas/tenth-edition/ 2. Instituto Nacional de Estadística y Censos (INDEC). Cuarta Encuesta Nacional de Factores de Riesgo. Resultados definitivos. 1a ed. Ciudad Autónoma de Buenos Aires. 3. Zhang Y, Lazzarini PA, McPhail SM, vanNetten JJ, Armstrong DG, Pacella RE. Global disability burdens of diabetes-related lower-extremity complications in 1990 and 2016. Diabetes Care 2020;43(5):964974. doi:10.2337/dc19-1614. 4. Boulton AJ. The pathway to foot ulceration in diabetes. Med Clin North Am 2013;97:775-790 (2013). doi: 10.1016/j.mcna.2013.03.007. 5. Armstrong DG, Boulton AJM, BusSA. Diabetic foot ulcers and their recurrence. N Engl J Med 2017; 376(24):2367-2375. doi:10.1056/NEJMra1615439. 6. Ndosi M, Wright-Hughes A, Brown S, et al. Prognosis of the infected diabetic foot ulcer: a 12-month prospective observational study. Diabet Med 2018;35(1):78-88. doi:10.1111/dme.13537. 7. Carro GV, Saurral R, Sagüez FS, Witman EL, Carrió M, Duturo CF, Dicatarina-Losada, MV, Braver JD, Illuminati G, Torres JC, David RA, Maldonado N. (2023). Estudio de diabetes mellitus y pie diabético en la internación: datos de Argentina. Rev Soc Arg Diab 2019;53(1):3-15. doi: 10.47196/diab.v53i1.136. 8. Senneville É, Albalawi Z, van Asten SA, et al. Guidelines on the diagnosis and treatment of foot infection in persons with diabetes: IWGDF/IDSA 2023. Diabetes Metab Rews Rev 2024;40(3):e3687. doi: 10.1002/dmrr.3687. 9. Ministerio de Salud de la Nación Argentina. Pautas para la prevención y el abordaje del pie diabético. Disponible en: https://bancos.salud.gob.ar/recurso/pautas-para-la-prevencion-y-el-abordaje-del-pie-diabetico. 10. IWGDF 2023 update. Guidelines on the classification of foot ulcers in people with diabetes. Disponible en: IWGDF Classification Guideline 2023 https://iwgdfguidelines.org/wp-content/uploads/2023/07/IWGDF-2023-03-Classification-Guideline.pdf 11. Carro GV, Saurral R, Carlucci E, Gette F, Llanos MLÁ, Amato PS. A comparison between diabetic foot classifications WIfI, Saint Elian, and Texas. Description of wounds and clinical outcomes. Int J Low Extrem Wounds 2022 Jun;21(2):120-130. doi: 10.1177/1534734620930171. 12. Carro GV, Saurral RN, Issa CM, Witman EL, Carrió M. Validación de clasificaciones de pie diabético en Argentina. Rev Soc Arg Diab 2023;57(2):84-94. doi: 10.47196/diab.v57i2.625. 13. Lazzarini PA, Pacella RE, Armstrong DG, van Netten JJ. Diabetes-related lower-extremity complications are a leading cause of the global burden of disability. Diabet Med 2018 May 23. doi: 10.1111/dme.13680. 14. Vainieri E, Ahluwalia R, Slim H, Vas PRJ. Outcomes after emergency admission with a diabetic foot attack indicate a high rate of healing and limb salvage but increased mortality: 18-month follow-up study. Exp Clin Endocrinol Diabetes 2022 Mar;130(3):165-171. doi: 10.1055/a-1322-4811. 15. Atkin L, Bućko Z, Conde-Montero E. Implementing TIMERS: the race against hard-to-heal wounds. J Wound Care 2019 Mar 1;23(Sup3a):S1-S50. doi: 10.12968/jowc.2019.28.Sup3a.S1. 16. Lantis-li JCL, Gordon I. Clostridial collagenase for the management of diabetic foot ulcers. Results of four randomized controlled trials. Wounds 2017;29(10):297-305. doi: 10.25270/wnds/2017.10.297305. 17. De Decker I, De Graeve L, Hoeksema H, Monstrey S, Verbelen J, De Coninck P, Vanlerberghe E, Claes KEY. Enzymatic debridement: past, present, and future. Acta Chir Belg 2022 Aug;122(4):279-295. doi: 10.1080/00015458.2022.2068746. 18. Chen L, Sun S, Gao Y, Ran X. Global mortality of diabetic foot ulcer. A systematic review and meta-analysis of observational studies. Diabetes Obes Metab 2023;25(1):36-45. doi: 10.1111/dom.14840. Publisher An entity responsible for making the resource available Lic. María Fernanda Cristoforetti Date A point or period of time associated with an event in the lifecycle of the resource 5/11/2024 Abbott Approach Collagenase proteolytic enzyme Diabetes diabetic foot Diabetic foot ulcer Mabel Carrió Treatment